Chronic Myeloid Leukemia (CML) is a type of cancer that affects the blood and bone marrow. It’s a chronic (long-term) disease, meaning it progresses slowly over time. CML is caused by a genetic mutation that produces an abnormal protein called BCR-ABL. This protein leads to the overproduction of white blood cells, which are an essential part of the immune system.
Understanding CML
What is Leukemia?
Leukemia is a broad term for cancers that begin in the blood-forming tissue of the bone marrow. There are several types of leukemia, including acute and chronic, based on how quickly the disease progresses. Chronic leukemias grow more slowly than acute leukemias.
Types of Leukemia
- Acute Leukemia: This type of leukemia grows rapidly and requires immediate treatment.
- Chronic Leukemia: This type grows more slowly and can often be managed with long-term treatment.
What is CML?
CML is a chronic leukemia that primarily affects adults. It is characterized by the presence of a specific chromosomal abnormality called the Philadelphia chromosome, which is the result of a translocation between chromosomes 9 and 22. This translocation creates the BCR-ABL fusion gene, which produces the BCR-ABL protein.
Symptoms of CML
The symptoms of CML can vary widely from person to person and may not be noticeable in the early stages. Common symptoms include:
- Fatigue
- Weakness
- Fever or night sweats
- Swelling or pain in the abdomen
- Shortness of breath
- Easy bruising or bleeding
- Swollen lymph nodes
Diagnosis
Diagnosing CML usually involves a combination of tests, including:
- Blood tests: These can show a high white blood cell count and the presence of the BCR-ABL protein.
- Bone marrow biopsy: This procedure involves taking a small sample of bone marrow to look for cancer cells.
- FISH (fluorescence in situ hybridization): This test can detect the Philadelphia chromosome and the BCR-ABL fusion gene.
- Cytogenetic analysis: This test examines the chromosomes for any abnormalities.
Treatment
Treatment for CML has improved significantly over the years, with new targeted therapies making it possible for many people to live long, healthy lives. Common treatments include:
- Tyrosine kinase inhibitors (TKIs): These drugs block the BCR-ABL protein’s activity, helping to control the cancer.
- Interferon therapy: This treatment helps to slow the growth of cancer cells and reduce the white blood cell count.
- Bone marrow transplant: This procedure involves replacing the diseased bone marrow with healthy bone marrow from a donor.
TKIs
TKIs are the mainstay of treatment for CML. They are taken daily and have been shown to be highly effective in reducing the risk of cancer progression and the need for bone marrow transplantation. Some of the most commonly used TKIs include:
- Imatinib (Gleevec)
- Nilotinib (Tasigna)
- Bosutinib (Bosulif)
- Dasatinib (Sprycel)
- Ponatinib (Iclusig)
Living with CML
Living with CML often requires regular medical follow-up and adherence to treatment. Many people with CML can lead normal lives with proper management of their condition. It’s important to maintain a healthy lifestyle, which includes:
- Eating a balanced diet
- Exercising regularly
- Avoiding smoking and excessive alcohol consumption
- Managing stress
Conclusion
CML is a complex disease, but with advances in treatment, it is now possible for many people to live long and productive lives. Early diagnosis and ongoing management are key to successful treatment outcomes. If you or someone you know has been diagnosed with CML, it’s important to work closely with a healthcare team to develop a personalized treatment plan.